Effects of initial BMI and on-treatment weight change on the lipid-lowering efficacy of fibrates

International Journal of Obesity

Volumn 21, Issue 2, 1997, Pages 155-158

  Muls, E ^a   Van Gaal, L ^a   Autier, P ^a   Vansant, G ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Atherosclerosis; Fibrates; Lipoproteins; Obesity; Weight loss

Indexed keywords

BEZAFIBRATE; CIPROFIBRATE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BELGIUM; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIET THERAPY; FEMALE; GENDER; GENERAL PRACTITIONER; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0031029146     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800370     Document Type: Article

References (15)